We are live on ! Find out more
AC

Arjuna Capital Portfolio holdings

AUM $393M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
+1.51%
1 Year Est. Return
+20.42%
3 Year Est. Return
+74.87%
5 Year Est. Return
+103.01%
10 Year Est. Return
–
AUM
$376M
AUM Growth
-$10.3M
Cap. Flow
-$10M
Cap. Flow %
-2.67%
Top 10 Hldgs %
43.88%
Holding
112
New
9
Increased
32
Reduced
54
Closed
13

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$3.1M
2
CSCO icon
Cisco
CSCO
+$2.93M
3
TJX icon
TJX Companies
TJX
+$1.79M
4
CMCSA icon
Comcast
CMCSA
+$1.79M
5
BXP icon
Boston Properties
BXP
+$1.58M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$3.93M
2
AMT icon
American Tower
AMT
+$3.34M
3
LRCX icon
Lam Research
LRCX
+$2.46M
4
DGX icon
Quest Diagnostics
DGX
+$2.3M
5
CNC icon
Centene
CNC
+$2.1M

Sector Composition

Rank Sector Weight
1 Technology 31.97%
2 Financials 14.86%
3 Consumer Discretionary 11.32%
4 Healthcare 10.62%
5 Communication Services 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CL icon
101
Colgate-Palmolive
CL
$73.1B
– –
-37,901
Closed -$3.93M
CNC icon
102
Centene
CNC
$30.7B
– –
-27,900
Closed -$2.1M
CVS icon
103
CVS Health
CVS
$133B
– –
-6,206
Closed -$390K
DLX icon
104
Deluxe
DLX
$1.18B
– –
-76,469
Closed -$1.49M
DOC icon
105
Healthpeak Properties
DOC
$15.1B
– –
-12,133
Closed -$277K
FDX icon
106
FedEx
FDX
$72.7B
– –
-5,740
Closed -$1.57M
FTEC icon
107
Fidelity MSCI Information Technology Index ETF
FTEC
$19.8B
– –
-1,974
Closed -$344K
LRCX icon
108
Lam Research
LRCX
$367B
– –
-30,090
Closed -$2.46M
QCOM icon
109
Qualcomm
QCOM
$155B
– –
-9,607
Closed -$1.63M
REGN icon
110
Regeneron Pharmaceuticals
REGN
$78.5B
– –
-282
Closed -$296K
SAN icon
111
Banco Santander
SAN
$202B
– –
-68,645
Closed -$350K
URTH icon
112
iShares MSCI World ETF
URTH
$7.99B
– –
-5,913
Closed -$928K
1 2 3 4
5

Similar funds

IAG
Investment Advisory Group Hanover, Massachusetts $393M AUM 16.75% 1-Year Est. Return
T
Tidemark San Diego, California $393M AUM 16.18% 1-Year Est. Return
SILC
Starr Indemnity & Liability Company New York $394M AUM 37.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Arjuna Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Arjuna Capital held 112 positions worth $376M, down 2.7% from $386M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Arjuna Capital's Q4 2024 filing shows 9 new, 32 increased, 54 reduced and 13 closed positions. Its largest new stake was Cisco: 51,226 shares worth $3.03M. The largest sale was Colgate-Palmolive, an estimated $3.93M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Arjuna Capital's largest Q4 2024 buy was Cisco: 51,226 shares worth $3.03M.
  • Arjuna Capital added most to GSK in Q4 2024, an estimated $3.1M increase.
  • Arjuna Capital's biggest Q4 2024 reduction was Quest Diagnostics, cutting an estimated $2.3M.
  • Arjuna Capital fully exited Colgate-Palmolive in Q4 2024, selling an estimated $3.93M.
  • Arjuna Capital's ten largest holdings make up 44% of its $376M portfolio in Q4 2024.
  • Arjuna Capital opened 9 new positions and closed 13 in Q4 2024.
  • Arjuna Capital's portfolio value fell 2.7% quarter-over-quarter to $376M.

Based on Arjuna Capital's 13F filing for Q4 2024, filed 7 Feb 2025.